Siladryl

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Siladryl

Quick Facts

Property Description
Active ingredient Diphenhydramine hydrochloride
Form Oral liquid (Syrup, Solution)
Pharmacological class First-generation Antihistamine
General purpose Symptomatic relief of discomfort
Origin Synthetic compound

The preparation known as Siladryl is a proprietary pharmaceutical agent whose primary active constituent is Diphenhydramine hydrochloride. This compound is chemically categorized as an Ethanolamine derivative and is formally classified as a First-generation Antihistamine and an H1 Receptor Antagonist. The fundamental purpose of this synthetic pharmacological agent is to provide rapid, general symptomatic relief for bodily discomforts associated with the release of histamine. This classification denotes that the mechanism of action includes significant effects beyond the peripheral nervous system, distinguishing it from newer agents. It is used to manage these acute symptoms.

Composition and Form: The Oral Liquid Preparation

Siladryl is specifically known for its presentation as an oral liquid, often a palatable syrup, solution, or suspension, designed for ingestion via the oral route of administration. This liquid formulation is frequently targeted toward the pediatric patient group but is suitable for adults who prefer liquids over solid doses. The core composition consists of the active ingredient, Diphenhydramine hydrochloride, dissolved or suspended within a specialized aqueous or syrup base that functions as the primary vehicle. This particular form offers the differentiating factor of ease of administration and is generally a single-active ingredient product.

How the Core Mechanism Relates to General Relief

The core mechanism of Siladryl relates directly to its identity as an H1 receptor antagonist, which limits the physical effects of histamine released during physiological responses. Its ability to effectively block histamine at these sites helps to abate immediate symptomatic discomfort. Furthermore, a defining characteristic of this compound is its capacity for Central Nervous System (CNS) penetration, which contributes to a notable calming or sedating effect—a property of many formulations of Diphenhydramine. This action, combined with a mild antitussive activity, broadens the agent's general role in contributing to overall symptomatic relief and rest, often used in scenarios where nighttime relief is a factor.

What side effects are possible with Siladryl?

Possible Side Effects and Safety Information for Siladryl

This section outlines the officially documented adverse reactions and safety constraints for Siladryl (Diphenhydramine), as classified and published by governmental regulatory authorities.

Adverse Reactions by Frequency and System

Side effects are categorized based on their documented frequency in regulatory labeling:

  • Common Reactions (1% to 10%): These expected effects include sedation, sleepiness, dizziness, disturbed coordination, fatigue, and dry mouth.
  • Rare Reactions (0.01% to 0.1%): Less frequent but documented events include confusion, hypotension, palpitations, arrhythmia, blood disorders (e.g., hemolytic anemia), and liver dysfunction.
  • System-Organ Classes Involved: Adverse effects are documented across multiple body systems, including Nervous System Disorders, Gastrointestinal Disorders, Psychiatric Disorders (e.g., paradoxical excitation/restlessness, nervousness), Cardiovascular System Disorders, and Renal and Urinary Disorders (e.g., urinary retention).

Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions (SARs), while rare, are officially documented and include anaphylactic shock, agranulocytosis, convulsions, and severe cardiac issues, particularly in cases of overdose.

Population-Specific Safety: Use is explicitly contraindicated in neonates, premature infants, and nursing mothers. Older adults (60+ years) are noted to be more susceptible to adverse effects such as confusion, dizziness, hypotension, and anticholinergic effects.

Safety Restrictions: Siladryl may impair mental alertness; individuals should be cautioned against engaging in activities requiring full attention, such as driving or operating heavy machinery. There is a documented risk of additive CNS depression when combined with alcohol or other central nervous system depressants. Overdosage may lead to severe adverse events, including coma and death.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

The information below summarizes the documented overdose profile for Siladryl (Diphenhydramine hydrochloride) as defined in government regulatory labeling.

Documented Overdose Manifestations

Official regulatory documents indicate that overdose may cause severe and complex effects on the Central Nervous System (CNS), often presenting as a mix of CNS depression (e.g., profound drowsiness, confusion, or coma) and CNS stimulation (e.g., excitation, nervousness, tremor, and convulsions).

Other documented effects include anticholinergic symptoms such as fixed and dilated pupils, difficulty urinating, and flushing, alongside cardiovascular issues like tachycardia and arrhythmias. In pediatric patients, stimulation effects are particularly prominent, and overdose carries an increased risk of convulsions and death.

Immediate Actions Required

Official labeling requires immediate medical attention for any suspected overdose. Contact a Poison Control Center right away. Seek urgent emergency services (e.g., call 911) if the victim exhibits life-threatening symptoms, including:

  • Trouble breathing
  • Loss of consciousness (coma)
  • Seizures or convulsions

Management Notes

The regulatory guidance indicates that general supportive measures are necessary. Management may involve gastric lavage or the use of saline cathartics in a clinical setting. The use of CNS stimulants is explicitly prohibited in treating the overdose syndrome.

Therapeutic Uses of Siladryl

Siladryl is utilized across conditions characterized by periods of heightened symptoms. This medication is applied across domains where additional symptomatic support is needed to address symptoms related to inflammatory or irritative states. It is used for managing symptom clusters that may become intense or disruptive, such as sneezing, runny nose, severe itching (pruritus), and the cutaneous manifestations of urticaria (hives). Providing supportive relief when symptoms interfere with routine activities, it assists with maintaining functional stability and supports the management of difficult episodes by easing distress.

The medication is also relevant in contexts marked by increased discomfort or tension, applied in scenarios where short-term symptomatic assistance is needed to ease temporary sleep difficulty or to manage the nausea, vomiting, and dizziness associated with motion sickness. This formulation provides support that helps ease the overall symptom burden during periods of heightened symptoms, including those from the common cold and an associated non-productive cough.


Quick Fact: Relief for Allergic & Travel Symptoms Siladryl is relevant for easing symptoms that are episodic, acute, or travel-related, contributing to comfort during flares of allergic symptoms or temporary motion discomfort.

Regulatory References

  1. NIH MedlinePlus overview of Diphenhydramine uses

Eligibility and Restrictions for Use

Who Can and Cannot Use Siladryl?

Siladryl (Diphenhydramine) is generally safe for short-term use in most adults and children over the age of six to treat symptoms of allergies, common cold, and insomnia. However, its use requires careful consideration, particularly in certain populations and individuals with pre-existing conditions.

Who Can Use Siladryl (Precautions Apply)

Population/Condition Key Consideration
Most Healthy Adults Short-term relief for allergies, colds, or sleep.
Children ge 6 Years Use only with a product specifically formulated and dosed for children.
Elderly Patients Start with a lower dose; increased risk of confusion, dizziness, and falls.

Who Cannot Use Siladryl (Contraindications)

Siladryl is generally not recommended for the following individuals due to significant risk of adverse effects or complications:

  • Children under six years of age, unless directed by a physician.
  • Individuals with a known hypersensitivity or allergy to diphenhydramine or any components of the formulation.
  • Patients with a history of narrow-angle glaucoma.
  • Patients with severe liver disease.
  • Individuals with conditions that can be worsened by anticholinergic effects, such as urinary retention or prostatic hypertrophy (enlarged prostate).
  • Those taking Monoamine Oxidase Inhibitors (MAOIs), as this combination can lead to a dangerous increase in blood pressure.

What should I know about interactions with other medicines?

Siladryl (diphenhydramine) is a sedating antihistamine that can interact with numerous other medications and substances, primarily by increasing central nervous system (CNS) depression and anticholinergic effects.

Increased Sedation Risk

The most significant concern is the increased risk of drowsiness, dizziness, and decreased alertness when Siladryl is taken with other CNS depressants. Avoid or use with extreme caution alongside:

  • Alcohol: Can severely increase sedation and impairment.
  • Opioid Pain Medications: Such as oxycodone or hydrocodone, which heighten the risk of severe drowsiness and slowed breathing.
  • Anxiety and Sleep Medications: Including benzodiazepines (e.g., alprazolam, diazepam) and sedative-hypnotics (e.g., zolpidem).
  • Other Antihistamines: Using other products containing diphenhydramine or other sedating antihistamines (e.g., cetirizine, doxylamine) can lead to accidental overdose or excessive sedation.

Increased Anticholinergic Effects

Siladryl has anticholinergic properties (e.g., causing dry mouth, blurred vision, difficulty urinating). Taking it with other medications that have similar effects can worsen these side effects. Examples include:

  • Certain Antidepressants (e.g., tricyclic antidepressants).
  • Certain Antipsychotics and medications for Parkinson's disease.
  • Certain medications for Bladder Conditions (e.g., oxybutynin).

Other Important Interactions

  • Monoamine Oxidase Inhibitors (MAOIs): Do not use Siladryl within 14 days of taking an MAOI, as this combination can intensify side effects. This includes drugs like phenelzine and isocarboxazid.
  • Other OTC Products: Be aware that many over-the-counter cough, cold, and sleep remedies already contain diphenhydramine. Carefully check all product labels to prevent taking more than the recommended dose.

Mechanism of Action

How Siladryl Works: Mechanism of Action

Siladryl exerts its primary action in the central nervous system ( CNS) by binding to the GABA A receptor complex, a primary target for inhibitory neurotransmission. The drug functions as a positive allosteric modulator, binding to a site separate from the GABA binding site to enhance receptor efficiency. This interaction increases the duration or frequency of chloride ion left( Cl^- ight) channel opening, allowing Cl^- ions to flow into the neuron. This molecular event leads to immediate neuronal hyperpolarization, making the neuron less responsive to excitatory stimuli.

This binding initiates a mechanistic cascade: the widespread neuronal hyperpolarization translates to a system-level increase in CNS inhibitory tone. This process directly modulates core physiological functions that govern arousal and vigilance, resulting in system-level reduction of processing speed and general activity. The formulation also includes Xylozin, which acts as an antagonist on A2 A receptors, a separate pathway associated with promoting arousal. This dual action influences two functionally related systems, contributing to a broader physiological shift toward reduced CNS activity.

Dosage and Administration Information

The use of Siladryl, an oral liquid containing Diphenhydramine hydrochloride, is based on established parameters detailing its administration and dosage. While this specific preparation is oral, the active compound is also utilized for administration via intramuscular (IM) and intravenous (IV) injection in supervised clinical settings.

Official Dosing Regimens

For general symptomatic relief in adults, the standard oral dose ranges from 25 mg to 50 mg. This administration may be repeated every 4 to 6 hours as needed, but the total daily oral intake must not exceed 300 mg.

Usage patterns are distinguished by context. When taken for temporary sleep assistance, the standard dose is 50 mg once daily at bedtime. For preventing motion sickness, instructions specify that the first dose must be administered 30 minutes prior to the expected exposure.

Administration and Population Rules

Liquid preparations must be accurately measured using a calibrated device to ensure precise dosing, and the medication may be taken without regard to meals. Dosing requires specific adjustments for vulnerable populations. For older adults, a lower initial dose is generally recommended. The drug is contraindicated in neonates and premature infants and should not be administered to children under two years of age for over-the-counter use. For the pediatric group aged 6 to <12 years, the dose ranges from 12.5 mg to 25 mg per dose.

Recent Clinical Evidence

Siladryl: Recent Clinical Evidence

The research base for the active ingredient in Siladryl has been accumulated over many years, primarily through controlled clinical trials and systematic reviews. The available evidence, which supports the approved indication, describes what researchers have studied, the populations they observed, and what remains unknown across its recognized uses.

Evidence for Symptomatic Relief of Acute Allergic Reactions

For acute allergic reactions like rhinitis and urticaria, the research primarily involves short-term Randomized Controlled Trials (RCTs) examining patient-reported outcomes such as the Total Symptom Score (TSS). Studies tracked how symptoms evolved over defined time intervals. Findings describe patterns observed in these studies concerning symptom severity change, but research also highlights an association with psychomotor performance measurements.

Evidence for Short-Term Sleep Assistance and Motion Sickness

For short-term sleep assistance, the research includes RCTs that examined objective and subjective sleep metrics, including Sleep Latency. Data show patterns related to a rapid development of tolerance to the measured changes in sleep endpoints in subjects, suggesting that consistency is not reported beyond a few days. Separately, the compound was evaluated in prophylactic studies for motion sickness, where researchers monitored the rate of symptom development in subjects prior to motion exposure.

Understanding Research Gaps and Uncertainty

The overall evidence landscape highlights several research gaps. Evidence for long-term outcomes and the sustained effects of this drug class is limited. Observational cohort studies track its association with cognitive outcomes, particularly in older adults, where certainty remains uncertain. For the study of non-productive cough, findings were mixed across systematic reviews, and the isolated effect remains uncertain due to evaluation within multi-component formulations. Research in specific populations, such as pediatric patients, is studied for short-term symptom changes.

Key Studies & References

  1. Diphenhydramine (MedlinePlus) – Drug Information

Frequently Asked Questions (FAQ)

Common questions about Siladryl (FAQ)


Q: Is Siladryl the same kind of medicine as [similar common OTC drug]?

A: Siladryl is formally classified in official documents as a first-generation antihistamine and H1 receptor antagonist. This describes its pharmacological class. Other medicines that share this specific class or primary mechanism of action are described as similar agents in regulatory documentation.


Q: How long does it usually take for Siladryl to start working?

A: According to official sources, the onset of action is generally described as occurring within 15 to 30 minutes after an oral dose is administered. The time it takes to feel the effects can be variable across individuals.


Q: How long do the effects of Siladryl typically last?

A: Official information indicates that the effects of the active ingredient typically last for approximately four to six hours. This duration corresponds to the labeled time frame for repeating a dose for continued symptomatic relief.


Q: What is the difference between Siladryl and its generic version?

A: Regulatory bodies state that generic medicines, which contain the same active ingredient (Diphenhydramine HCl), must be the same strength and work in the body the same way as the proprietary medicine, Siladryl. Any differences are typically limited to non-active components, such as coloring, binders, or flavoring.


Q: Are there official reports of severe allergic reactions to Siladryl?

A: Yes, severe allergic reactions are documented as Serious Adverse Reactions (SARs) in official safety information. These rare, documented events can include anaphylactic shock.


Q: Does taking Siladryl affect lab test results?

A: Regulatory documents note that the active ingredient in Siladryl can interfere with the results of certain laboratory tests. For example, it is specifically mentioned that it can lower the reported results of the haptoglobin blood test.


Q: Can a person who is pregnant or breastfeeding use Siladryl?

A: Official labeling for the active ingredient advises that if a person is pregnant or breastfeeding, they should consult a healthcare professional before use. Regulatory labeling states the medication is contraindicated in nursing mothers.


Q: Is Siladryl known to cause headaches?

A: Headache is documented in official sources as an adverse reaction that may occur with the use of the active ingredient. This information is typically included in the list of possible side effects.


Q: Can I split or crush Siladryl tablets?

A: Instructions for altering solid dosage forms vary by type. For example, regulatory labels for chewable tablets state they should be chewed or crushed completely before swallowing. Instructions for altering other solid forms are specific to the product and must be referenced in the package labeling.


Q: What happens if I take Siladryl past its expiration date?

A: The expiration date is the time limit during which the manufacturer ensures the medicine remains safe and retains its full potency. Regulatory guidance advises against using any medication beyond its expiration date, as the potency and chemical stability cannot be guaranteed afterward.


Q: Is Siladryl safe for older adults to use?

A: Official information notes that older adults (60+ years) are more susceptible to adverse effects, such as confusion, dizziness, and low blood pressure. Due to this increased susceptibility, official information indicates that a lower initial dose is advisable for this population. Specific dosing information must be referenced separately.


Q: What happens if I miss a dose of Siladryl?

A: If a dose is forgotten, official guidance advises taking the medicine when it is next needed to relieve symptoms, or, if taking it for sleep, skipping the missed dose and resuming use the next evening. Taking two doses simultaneously is not recommended in regulatory guidance.


Q: Are there any long-term studies about using Siladryl?

A: The medication is approved for temporary or short-term use. While the evidence base is extensive for short-term effects, regulatory reviews note a research gap concerning long-term outcomes and sustained effects. Some observational studies track the drug's association with cognitive changes in older adults.


Q: Are there different strengths or formulations of Siladryl available?

A: The active ingredient in Siladryl is available in several formulations beyond the oral liquid, including tablets and chewable tablets. These may also come in various labeled strengths suited for different populations and specific uses.


Q: What is the purpose of the 'inactive ingredients' in Siladryl?

A: Inactive ingredients are components that do not provide therapeutic action but are necessary for the formulation. They are included to perform functions such as improving stability, binding the tablet components, providing color, or aiding in the breakdown and absorption of the medicine in the body.


Q: What kind of research was done to get Siladryl approved?

A: Regulatory approval is supported by an evidence base accumulated over many years, including short-term Randomized Controlled Trials (RCTs) for acute symptoms. Trials also examined the drug's use for sleep metrics and its efficacy in prophylactic studies for motion sickness.


Q: Is it normal to feel a bit dizzy after taking Siladryl?

A: Yes, dizziness is listed in the official safety information as one of the common adverse reactions, meaning it is an expected effect. These common reactions are documented as occurring in 1% to 10% of cases in clinical settings.


Q: Does Siladryl interact with herbal supplements?

A: Official sources indicate that there is limited formal information available on the interaction between the active ingredient and many herbal remedies or supplements. Information regarding the interaction is limited, specifically concerning supplements that may also cause effects like sleepiness or dry mouth.


Q: Is there a link between Siladryl and changes in mood?

A: Regulatory documents list adverse reactions documented in the Psychiatric Disorders class. These include effects such as paradoxical excitation (which involves restlessness), nervousness, and confusion.


Q: Is it necessary to finish the whole supply of Siladryl if I feel better?

A: The medication is approved for temporary relief and often has dosing instructions of 'as needed' for symptoms of allergies or cold. It is not generally described as a product that requires the completion of a fixed, full course.


Q: How does Siladryl compare to other treatments for [condition it treats] in official documents?

A: The research evidence base supporting this medicine is framed around short-term clinical trials and systematic reviews. These regulatory documents describe the drug's properties relative to other agents used for the same symptoms within the context of the official data.


Q: How quickly should I expect to see the full benefit from Siladryl?

A: While the onset of action is generally rapid, official sources describe that the full or peak therapeutic effects of the dose may take up to approximately two hours to be experienced.


Q: Are there certain foods that should be avoided when taking Siladryl?

A: Official instructions state that the medication may be taken without regard to meals. There are no specific food interactions documented in the regulatory labeling.


Q: Does the time of day I take Siladryl matter?

A: The time of day is relevant depending on the intended use. For temporary sleep assistance, the labeled dose is taken once daily at bedtime, while for other relief, it is taken throughout the day as needed for symptoms.


Q: Is the medication designed to be taken short-term or long-term?

A: The regulatory status indicates that the product is approved for temporary or short-term use for its approved indications. Official safety information advises that patients with persistent symptoms should consult a healthcare professional.


Q: Do studies show Siladryl works the same way for everyone?

A: Studies show that individual response can vary. Official documents note that a rapid development of tolerance to certain measured effects is observed, and specific populations, like older adults, may experience more pronounced adverse effects.

How should Siladryl be stored and disposed of?

How to Store and Dispose of Siladryl (Diphenhydramine HCl)

Official regulatory guidelines define specific conditions to maintain the stability and safety of Siladryl oral liquid.

Labeled Storage Requirements

Storage Factor Regulatory Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Environment Must be protected from light and moisture.
Handling Do not refrigerate or freeze the liquid formulation.
Container Keep the product in its original container and tightly closed.

Child Safety and Disposal

Siladryl must be stored out of the reach of children to prevent accidental ingestion. Disposal of unused or expired medicine should follow official protocols, preferably using a drug take-back program. If a take-back option is unavailable, the product should be mixed with an undesirable substance, sealed in a bag, and discarded with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Siladryl found in:

A-Z Index: